These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6946282)

  • 1. Podophyllotoxin resistance: a codominant selection system for quantitative mutagenesis studies in mammalian cells.
    Gupta RS
    Mutat Res; 1981 Sep; 83(2):261-70. PubMed ID: 6946282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to the microtubule inhibitor podophyllotoxin: selection and partial characterization of mutants in CHO cells.
    Gupta RS
    Somatic Cell Genet; 1981 Jan; 7(1):59-71. PubMed ID: 7194518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative mutagenesis at the adenosine kinase locus in Chinese hamster ovary cells. Development and characteristics of the selection system.
    Gupta RS; Singh B
    Mutat Res; 1983 Aug; 113(5):441-54. PubMed ID: 6308439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Podophyllotoxin-resistant mutants of Chinese hamster ovary cells: cross-resistance studies with various microtubule inhibitors and podophyllotoxin analogues.
    Gupta RS
    Cancer Res; 1983 Feb; 43(2):505-12. PubMed ID: 6848174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic markers in mouse teratocarcinoma cells. Selection and partial characterization of mutants resistant to toyocamycin, DRB and podophyllotoxin.
    Gupta RS; Hodgson M
    Exp Cell Res; 1981 Apr; 132(2):496-500. PubMed ID: 6938375
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetic markers for quantitative mutagenesis studies in Chinese hamster ovary cells: characteristics of some recently developed selective systems.
    Gupta RS; Siminovitch L
    Mutat Res; 1980 Jan; 69(1):113-26. PubMed ID: 6987491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Podophyllotoxin-resistant mutants of Chinese hamster ovary cells. Alteration in a microtubule-associated protein.
    Gupta RS; Ho TK; Moffat MR; Gupta R
    J Biol Chem; 1982 Jan; 257(2):1071-8. PubMed ID: 7054166
    [No Abstract]   [Full Text] [Related]  

  • 8. Induction and expression of mutations at multiple drug-resistance marker loci in Chinese hamster ovary cells.
    Adair GM; Carver JH
    Environ Mutagen; 1983; 5(2):161-75. PubMed ID: 6574908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of selection cell density on the recovery of mutagen-induced 6-thioguanine-resistant cells (CHO/HGPRT system).
    O'Neill JP; Bowman KO
    Environ Mutagen; 1982; 4(6):627-37. PubMed ID: 7160342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of 2-benzimidazolyl urea as a new antimitotic compound based on cross resistance studies with nocodazole resistance mutants of CHO cells.
    Gupta RS
    Biochem Biophys Res Commun; 1987 Feb; 143(1):225-32. PubMed ID: 3827918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postreplication repair and the susceptibility of Chinese hamster cells to cytotoxic and mutagenic effects of alkylating agents.
    Friedman J; Huberman E
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6072-6. PubMed ID: 6934532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-resistance of nocodazole-resistant mutants of CHO cells toward other microtubule inhibitors: similar mode of action of benzimidazole carbamate derivatives and NSC 181928 and TN-16.
    Gupta RS
    Mol Pharmacol; 1986 Aug; 30(2):142-8. PubMed ID: 3736539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutagenic responses of five independent genetic loci in CHO cells to a variety of mutagens. Development and characteristics of a mutagen screening system based on selection for multiple drug-resistant markers.
    Gupta RS; Singh B
    Mutat Res; 1982 Jun; 94(2):449-66. PubMed ID: 7110183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxicity and mutagenicity of alkylating agents in cultured mammalian cells (CHO/HGPRT system): mutagen treatment in the presence or absence of serum.
    O'Neill JP; Schenley RL; Hsie AW
    Mutat Res; 1979 Dec; 63(2):381-5. PubMed ID: 522878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagenicity testing in mammalian cells. II. Validation of multiple drug-resistance markers having practical application for screening potential mutagens.
    Carver JH; Adair GM; Wandres DL
    Mutat Res; 1980 Sep; 72(2):207-30. PubMed ID: 6449664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mutagen-testing assay based on heterogeneity in diameter and integrated optical density of mammalian cell colonies.
    Dairkee SH; Glaser DA
    Proc Natl Acad Sci U S A; 1984 Apr; 81(7):2112-6. PubMed ID: 6585791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated mutagenesis and the selection of recessive and dominant mutations in cultured mammalian cells.
    Gupta RS
    Mutat Res; 1980 Dec; 74(6):503-8. PubMed ID: 6936610
    [No Abstract]   [Full Text] [Related]  

  • 18. Mutagenesis at the ouabain-resistance locus in human diploid fibroblasts.
    Buchwald M
    Mutat Res; 1977 Sep; 44(3):401-11. PubMed ID: 904650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A procedure for the CHO/HGPRT mutation assay involving treatment of cells in suspension culture and selection of mutants in soft-agar.
    Oberly TJ; Bewsey BJ; Probst GS
    Mutat Res; 1987 Apr; 182(2):99-111. PubMed ID: 3561430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DRB resistance in Chinese hamster and human cells: genetic and biochemical characteristics of the selection system.
    Gupta RS; Siminovitch L
    Somatic Cell Genet; 1980 Mar; 6(2):151-69. PubMed ID: 6930702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.